Changes in Ownership

Alector, Inc. Filed 2019-02-11 Acc 0001209191-19-009118

Director bought 411,700 shares at $19.00 ($7,822,300)

Director acquired 12,682,329 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion	+405,925			405,925	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion	+4,282,288			4,688,213	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion	+2,029,626			6,717,839	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion	+2,280,479			8,998,318	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion	+1,012,282			10,010,600	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion	+266,437			10,277,037	I
ORBIMED ADVISORS LLC Director	2019-02-11	Purchase	+157,939	$19.00	$3,000,841	10,434,976	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion	+94,075			94,075	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion	+992,437			1,086,512	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion	+470,374			1,556,886	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion	+528,510			2,085,396	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion	+234,601			2,319,997	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion	+85,295			2,405,292	I
ORBIMED ADVISORS LLC Director	2019-02-11	Purchase	+50,561	$19.00	$960,659	2,455,853	I
ORBIMED ADVISORS LLC Director	2019-02-11	Purchase	+203,200	$19.00	$3,860,800	203,200	I
Derivatives
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion · Series A-1 Preferred Stock	−405,925			0	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion · Series A-1 Preferred Stock	−94,075			0	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion · Series A-2 Preferred Stock	−4,282,288			0	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion · Series A-2 Preferred Stock	−992,437			0	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion · Series B Preferred Stock	−2,029,626			0	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion · Series B Preferred Stock	−470,374			0	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion · Series C Preferred Stock	−2,280,479			0	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion · Series C Preferred Stock	−528,510			0	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion · Series D Preferred Stock	−1,012,282			0	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion · Series D Preferred Stock	−234,601			0	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion · Series E Preferred Stock	−266,437			0	I
ORBIMED ADVISORS LLC Director	2019-02-11	Conversion · Series E Preferred Stock	−85,295			0	I
Open-market purchases · 411,700 sh · avg $19.00 · $7,822,300